loader
Please Wait
Applying Filters...

Manufacturers & Suppliers of DSSTox_CID_3109 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
$ API Ref.Price (USD/KG) : 26,220Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Ethypharm

02 1Granules India Limited

03 1Biological E

04 3CHEMO

05 1Cooper Pharma Limited

06 4Farbe Firma

07 2Farmaprojects S.A.U

08 1Indoco Remedies Limited

09 2Intas Pharmaceuticals

10 2Myungmoon Pharm. Co., LTD.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEthypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Regulatory Info :

Registration Country : France

Glycopyrronium Bromide

Brand Name :

Dosage Form : Ampoule

Dosage Strength : 200MCG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : France

Ethypharm

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEthypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Packaging :

Regulatory Info :

Glycopyrronium Bromide

Dosage : Ampoule

Dosage Strength : 200MCG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : France

Ethypharm

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info : ROW, US

Registration Country : India

Glycopyrronium Bromide

Brand Name :

Dosage Form : Oral Solution

Dosage Strength : 1MG/5ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : ROW, US

Registration Country : India

Granules India

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Packaging :

Regulatory Info : ROW, US

Glycopyrronium Bromide

Dosage : Oral Solution

Dosage Strength : 1MG/5ML

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Granules India

03

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrrolate

Brand Name :

Dosage Form : Vial

Dosage Strength : 0.2MG/ML

Packaging : 1ml, 2 ml, 5 ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

03

Boulder Peptide 2024
Not Confirmed
arrow

04

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Brand Name :

Dosage Form : Capsule - Powder for I...

Dosage Strength : 44MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

04

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Dosage : Capsule - Powder for I...

Dosage Strength : 44MCG

Brand Name :

Approval Date :

Application Number :

Registration Country : Spain

blank

05

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Indacaterol; Glycopyrronium Bromide

Brand Name :

Dosage Form : Capsule - Powder for I...

Dosage Strength : 85MCG; 43MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

05

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Indacaterol; Glycopyrronium Bromide

Dosage : Capsule - Powder for I...

Dosage Strength : 85MCG; 43MCG

Brand Name :

Approval Date :

Application Number :

Registration Country : Spain

blank

06

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Brand Name :

Dosage Form : Aqueous Suspension

Dosage Strength : 0.2MG/ML

Packaging : 1ML, 2ML, 5ML, 20ML

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

06

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Dosage : Aqueous Suspension

Dosage Strength : 0.2MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : Spain

blank

07

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Brand Name :

Dosage Form : Injection

Dosage Strength : 0.2MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

07

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Dosage : Injection

Dosage Strength : 0.2MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

08

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Brand Name :

Dosage Form : Injection

Dosage Strength : 0.2MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

08

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Dosage : Injection

Dosage Strength : 0.2MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

09

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Brand Name :

Dosage Form : Injection

Dosage Strength : 0.2MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

09

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Dosage : Injection

Dosage Strength : 0.2MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

10

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Brand Name :

Dosage Form : Injection

Dosage Strength : 0.2MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

10

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Dosage : Injection

Dosage Strength : 0.2MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

11

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Brand Name :

Dosage Form : Injection

Dosage Strength : 0.2MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

11

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Dosage : Injection

Dosage Strength : 0.2MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

12

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrronium Bromide

Brand Name :

Dosage Form : Inhalation Powder

Dosage Strength : 44MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

12

Boulder Peptide 2024
Not Confirmed
arrow

13

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Indacaterol Maleate; Glycopyrronium Bromide

Brand Name :

Dosage Form : Inhalation Powder

Dosage Strength : 85; 43

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

13

Boulder Peptide 2024
Not Confirmed
arrow

14

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrrolate

Brand Name :

Dosage Form : Injection

Dosage Strength : 0.2MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

14

Boulder Peptide 2024
Not Confirmed
arrow

15

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrrolate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

15

Boulder Peptide 2024
Not Confirmed
arrow

16

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrrolate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

16

Boulder Peptide 2024
Not Confirmed
arrow

17

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrrolate

Brand Name : Glycopyrrolate

Dosage Form : TABLET

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Korea

blank

17

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrrolate

Dosage : TABLET

Dosage Strength : 1MG

Brand Name : Glycopyrrolate

Approval Date :

Application Number :

Registration Country : South Korea

blank

18

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrrolate

Brand Name : Mobinul

Dosage Form : INJECTION

Dosage Strength : 0.2MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Korea

blank

18

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Glycopyrrolate

Dosage : INJECTION

Dosage Strength : 0.2MG/ML

Brand Name : Mobinul

Approval Date :

Application Number :

Registration Country : South Korea

blank